Furthermore, it addresses the FDA’s communications with the applicant, the retention of records that assist the SE report, confidentiality of an SE report, how an applicant can amend or withdraw an SE report, how an applicant may transfer possession of the SE report back to a different applicant and Digital submission on the SE report and amendme